-Bloomberg
BioCardia Enters Agreement with BlueRock Therapeutics To Provide Enabling Catheter Biotherapeutic Delivery Product Candidates For BlueRock’s Cell Therapy To Treat Heart Failure
BioCardia®, Inc. (NASDAQ:BCDA), today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of BlueRock's cell therapy product candidates for the treatment of